192 related articles for article (PubMed ID: 21474923)
21. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
Lambertucci JR; Leão FC; Barbosa AJ
Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738
[No Abstract] [Full Text] [Related]
22. Duodenal obstruction due to
Harshan M; Niyas VKM; Arjun R
Trop Doct; 2022 Oct; 52(4):596-597. PubMed ID: 35833224
[No Abstract] [Full Text] [Related]
23. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM
Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545
[TBL] [Abstract][Full Text] [Related]
24. [Duodenal Linphoma asociated to Strongyloides stercoralis infection. Two types of HTLV-1 infection].
Guevara Miranda J; Guzmán Rojas P; Espinoza-Ríos J; Mejía Cordero F
Rev Gastroenterol Peru; 2017; 37(2):169-172. PubMed ID: 28731999
[TBL] [Abstract][Full Text] [Related]
25. Coinfection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in São Paulo City, Brazil.
Chieffi PP; Chiattone CS; Feltrim EN; Alves RC; Paschoalotti MA
Mem Inst Oswaldo Cruz; 2000; 95(5):711-2. PubMed ID: 10998221
[TBL] [Abstract][Full Text] [Related]
26. Utility of PCR in Patients with
Blaizot R; Simon S; Brottier J; Blanchet D; Brousse P; Boukhari R; Demar M
Am J Trop Med Hyg; 2019 Oct; 101(4):848-850. PubMed ID: 31436152
[No Abstract] [Full Text] [Related]
27. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
[TBL] [Abstract][Full Text] [Related]
28. Image of the month: Target the bugs:
Hokama A; Kishimoto K
Clin Med (Lond); 2021 Mar; 21(2):e239-e240. PubMed ID: 33762395
[TBL] [Abstract][Full Text] [Related]
29. [Combined infection with HTLV-1 and Strongyloides stercoralis].
Pays JF
Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
[TBL] [Abstract][Full Text] [Related]
30. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
[TBL] [Abstract][Full Text] [Related]
31. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
Einsiedel L; Fernandes L
Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
[TBL] [Abstract][Full Text] [Related]
32. Strongyloidiasis presenting as duodenal obstruction in a patient infected with human T-cell lymphotropic virus type 1.
Hindy P; Parvin R; Hanna K; Gress F
Gastrointest Endosc; 2011 Aug; 74(2):439-41. PubMed ID: 21704987
[No Abstract] [Full Text] [Related]
33. Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody.
Zaha O; Hirata T; Uchima N; Kinjo F; Saito A
J Infect Chemother; 2004 Dec; 10(6):348-51. PubMed ID: 15614460
[TBL] [Abstract][Full Text] [Related]
34. Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.
Choksi TT; Madison G; Dar T; Asif M; Fleming K; Clarke L; Danilewitz M; Hennawy R
Am J Trop Med Hyg; 2016 Oct; 95(4):864-867. PubMed ID: 27527631
[TBL] [Abstract][Full Text] [Related]
35. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
[TBL] [Abstract][Full Text] [Related]
36. [Strongyloides hyperinfection in patient from Patagonia with HTLV-1 co-infection].
Hunter M; Beltramino S; Vera Ocampo C; Sánchez Marull R; Badariotti G; De Diego B
Medicina (B Aires); 2019; 79(2):147-149. PubMed ID: 31048281
[TBL] [Abstract][Full Text] [Related]
37. Recurrent Enterococcus faecalis meningitis in a patient presenting with Strongyloides hyperinfection syndrome during HTLV-1-induced T-cell lymphoma.
Schein F; Fouillet L; Lutz MF; Daguenet E; Botelho-Nevers E; Cornillon J
Med Mal Infect; 2018 Sep; 48(6):428-430. PubMed ID: 29884325
[No Abstract] [Full Text] [Related]
38. Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).
Agapé P; Copin MC; Cavrois M; Panelatti G; Plumelle Y; Ossondo-Landeau M; Quist D; Grossat N; Gosselin B; Fenaux P; Wattel E
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(4):394-402. PubMed ID: 10096585
[TBL] [Abstract][Full Text] [Related]
39. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
40. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression.
Newton RC; Limpuangthip P; Greenberg S; Gam A; Neva FA
Am J Med; 1992 Feb; 92(2):202-8. PubMed ID: 1543206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
